Erasca, Inc.
ERAS NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 12, 2026
ET
EPS Est.
-0.11
EPS Actual
-0.14
Revenue Est.
--
Revenue Actual
--
Next Earnings Report
Date
Nov 11, 2026 · Wed
Time
Time TBD
Fiscal Period
FY2026 Q3
EPS Est.
-0.13
Revenue Est.
--
Company Overview
Erasca, Inc. (ticker ERAS) is listed on NASDAQ with a market cap of about $6.12B. Its next earnings report (FY2026 Q3) is expected on Nov 11, 2026 (ET), Time TBD, with consensus EPS of -0.13. In the last 15 reported quarters, EPS beat consensus estimates 9 times.
Actual EPS TrendRecently15Term · Mar 23, 2023 → Aug 12, 2026
Mar 23, 2023Range: -0.60 ~ -0.10Aug 12, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 12, 2026 | -- | -0.11 | Below forecast↓-0.14 | -- | -- |
| May 11, 2026 | -- | -0.11 | Below forecast↓-0.60 | -- | -- |
| Mar 12, 2026 | -- | -0.11 | -0.10 | -- | -- |
| Nov 12, 2025 | -- | -0.11 | -0.11 | -- | -- |
| Aug 12, 2025 | -- | -0.12 | -0.12 | -- | -- |
| May 13, 2025 | -- | -0.12 | -0.11 | -- | -- |
| Mar 20, 2025 | -- | -0.12 | -0.11 | -- | -- |
| Nov 12, 2024 | -- | -0.17 | Above forecast↑-0.11 | -- | -- |
| Aug 12, 2024 | -- | -0.17 | Below forecast↓-0.29 | -- | -- |
| May 8, 2024 | -- | -0.21 | -0.23 | -- | -- |
| Mar 27, 2024 | -- | -0.24 | Above forecast↑-0.20 | -- | $5.6M |
| Nov 9, 2023 | -- | -0.21 | -0.20 | -- | -- |
| Aug 10, 2023 | -- | -0.27 | Above forecast↑-0.21 | -- | -- |
| May 15, 2023 | -- | -0.30 | Above forecast↑-0.22 | -- | -- |
| Mar 23, 2023 | -- | -0.30 | -0.28 | -- | -- |
Original Filings (SEC)
Quarterly10-Q · 2026-08-11 ↗
Earnings Release8-K · 2026-08-11 ↗
Quarterly10-Q · 2026-05-11 ↗
Earnings Release8-K · 2026-05-11 ↗
Annual10-K · 2026-03-12 ↗
Earnings Release8-K · 2026-03-12 ↗
Quarterly10-Q · 2025-11-12 ↗
Earnings Release8-K · 2025-11-12 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
